V Chapman
Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis.
Chapman, V; Markides, H; Sagar, DR; Xu, L; Kay, A; Burston, JJ; Mapp, P; Morris, RH; Kehoe, O; El Haj, AJ
Authors
H Markides
DR Sagar
L Xu
A Kay
JJ Burston
P Mapp
RH Morris
Oksana Kehoe o.kehoe@keele.ac.uk
AJ El Haj
Abstract
Background: Mesenchymal stem cells (MSCs) have a therapeutic potential for the treatment of osteoarthritic (OA) joint pathology and pain. The aims of this study were to determine the influence of a passage number on the effects of MSCs on pain behaviour and cartilage and bone features in a rodent model of OA. Methods: Rats underwent either medial meniscal transection (MNX) or sham surgery under anaesthesia. Rats received intra-articular injection of either 1.5?×?106late passage MSCs labelled with 10?µg/ml SiMAG, 1.5?×?106late passage mesenchymal stem cells, the steroid Kenalog (200?µg/20?µL), 1.5?×?106early passage MSCs, or serum-free media (SFM). Sham-operated rats received intra-articular injection of SFM. Pain behaviour was quantified until day 42 postmodel induction. Magnetic resonance imaging (MRI) was used to localise the labelled cells within the knee joint. Results: Late passage MSCs and Kenalog attenuated established pain behaviour in MNX rats, but did not alter MNX-induced joint pathology at the end of the study period. Early passage MSCs exacerbated MNX-induced pain behaviour for up to one week postinjection and did not alter joint pathology. Conclusion: Our data demonstrate for the first time the role of a passage number in influencing the therapeutic effects of MSCs in a model of OA pain.
Acceptance Date | Sep 7, 2017 |
---|---|
Publication Date | Dec 24, 2017 |
Publicly Available Date | Mar 29, 2024 |
Journal | Stem Cells International |
Print ISSN | 1687-966X |
Publisher | Hindawi |
Pages | 2905104 - ? |
DOI | https://doi.org/10.1155/2017/2905104 |
Publisher URL | https://www.hindawi.com/journals/sci/2017/2905104/ |
Files
A El Haj - Therapeutic benefit for late but not early passage....pdf
(4.9 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Syndecan-3: A Signaling Conductor in the Musculoskeletal System
(2021)
Book Chapter
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search